InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company, announced today that its BTK inhibitor orelabrutinib received approval from the China National Medical Products ...

JPMorgan: Turned Bearish on 2025 Base Metal Prices The tariff issue was gradually digested, and non-ferrous metals fluctuated rangebound. [Institutional Commentary] LME base metals rose, and copper ...